|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| G01N 33/48 | (2006.01) | ||
| A61K 31/12 | (2006.01) |
| (11) | Number of the document | 2650380 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13167176.0 |
| Date of filing the European patent application | 2008-07-31 | |
| (97) | Date of publication of the European application | 2013-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 953074 P | 2007-07-31 | US |
| (72) |
Henderson, Samuel T., US
|
| (73) |
Accera, Inc.,
380 Interlocken Crescent, Suite 780, Broomfield, Colorado 80021,
US
|
| (54) | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |